Huang, Yu-Ting
Hsieh, Yung-Yu
Chen, Wei-Ming
Tung, Shui-Yi
Wei, Kuo-Liang
Shen, Chen-Heng
Chang, Kao-Chi
Lu, Chung-Kuang
Yen, Chih-Wei
Lu, Sheng-Nan
Hung, Chao-Hung
Chang, Te-Sheng
Article History
Received: 19 April 2021
Accepted: 31 May 2021
First Online: 12 June 2021
Declarations
:
: This study was approved by the Institutional Review Board of Chang Gung Medical Foundation. All patients gave written informed consent prior to the initiation of sofosbuvir/velpatasvir therapy. This study was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization for Good Clinical Practice.
: Not applicable.
: The authors declare that they have no conflicts of interest.